As of February 2026, the global pharmaceutical landscape is witnessing a significant shift toward non-invasive systemic therapy, with the Transdermal Drug Delivery Systems Market emerging as a critical vertical for managing chronic pathologies. The transition from simple passive diffusion patches to "active" delivery systems—including iontophoresis, electroporation, and...